Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes – Labiotech.eu (blog)
Labiotech.eu (blog) |
Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
Labiotech.eu (blog) BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other conditions using a unique cell culture matrix technology. BioLamina, based in Stockholm, is collaborating with the world-leader in diabetes treatment Novo … |
